🇺🇸 FDA
Patent

US 7829102

Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 7829102 (Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/544, A61K39/00